{"database": "lobbying", "table": "lobbying_activities", "rows": [[3045469, "0fdbec0f-0a16-4dae-9f46-ab00d474bfde", "Q3", "ALTRIUS GROUP, LLC", 40022172, "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA", 2023, "third_quarter", "TRD", "WTO proposed Covid IP waiver", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2023-10-06T11:00:39-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3045469"], "units": {}, "query_ms": 21.382770966738462, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}